Commit To Purchase Clovis Oncology At $40, Earn 24.8% Annualized Using Options
May 26, 2017 at 11:37 AM EDT
Investors considering a purchase of Clovis Oncology Inc (CLVS) shares, but cautious about paying the going market price of $53.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $40 strike, which has a bid at the time of this writing of $4.00..